NCT04065555 2022-07-29Intratumoral Microdosing of TAK-981 in Head and Neck CancerPresage BiosciencesPhase EARLY_PHASE1 Completed12 enrolled
NCT03158883 2021-10-20UCDCC#270: Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC PatientsUniversity of California, DavisPhase EARLY_PHASE1 Completed8 enrolled